Valuation: Boston Scientific Corporation

Market Cap 68.43B 60.13B 56.13B 51.51B 96.42B 6,555B 98.8B 666B 260B 3,244B 257B 251B 11,213B P/E 2026 *
16.8x
P/E 2027 * 17.1x
Enterprise Value 78.78B 69.23B 64.62B 59.3B 111B 7,546B 114B 766B 300B 3,734B 296B 289B 12,909B EV / Sales 2026 *
3.68x
EV / Sales 2027 * 3.31x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day-2.57%
1 week+3.40%
Current month+5.58%
1 month+5.58%
3 months-21.78%
6 months-51.82%
Current year-52.74%
1 week 42.55
Extreme 42.55
47.16
1 month 42.2
Extreme 42.2
47.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
01/07/26 Fiscal year

Chief Financial Officer

5,184 0.0004%
01/03/26 Fiscal year

Controller/Auditor

2,048 0.0001%
19/02/26 Other

Executive/Senior Manager

6,851 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+3.40%-57.79%-13.10% 68.43B
-1.90%-1.16%+18.52%+3.10% 214B
-0.53%+1.68%-4.05%-23.26% 138B
-0.20%+6.75%-29.19%+9.26% 125B
-0.44%+1.81%+5.14%+3.98% 49.38B
-1.29%+8.99%-25.06%-29.78% 47.55B
-0.69%-0.69%+17.43%+13.85% 39.63B
-0.93%-2.04%+25.26%+35.63% 37.26B
-3.75%+12.27%-2.85%-10.78% 32.71B
-2.48%+9.08%-24.56%-5.87% 30.91B
Average -1.47%+7.51%-7.71%-1.70% 78.3B
Weighted average by Cap. -1.28%+7.67%-5.55%-2.77%

Financials

2026 *2027 *
Net sales 21.43B 18.83B 17.58B 16.13B 30.2B 2,053B 30.95B 208B 81.52B 1,016B 80.47B 78.72B 3,512B 22.58B 19.84B 18.52B 16.99B 31.81B 2,162B 32.6B 220B 85.87B 1,070B 84.76B 82.92B 3,699B
Net income 3.71B 3.26B 3.05B 2.8B 5.23B 356B 5.36B 36.12B 14.13B 176B 13.95B 13.64B 609B 3.91B 3.44B 3.21B 2.94B 5.51B 375B 5.65B 38.05B 14.88B 185B 14.69B 14.37B 641B
Net Debt 10.35B 9.1B 8.49B 7.79B 14.59B 992B 14.95B 101B 39.38B 491B 38.87B 38.03B 1,696B 6.33B 5.56B 5.19B 4.76B 8.91B 606B 9.13B 61.52B 24.06B 300B 23.75B 23.23B 1,036B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
30/07/26 $45.02 -2.22% 1,882,938
29/07/26 $46.04 -0.04% 51,286,660
28/07/26 $46.06 +1.21% 26,905,670
27/07/26 $45.51 +2.85% 20,044,682
24/07/26 $44.25 +1.54% 20,689,854
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
46.04USD
Average target price
65.34USD
Spread / Average Target
+41.93%

Quarterly revenue - Rate of surprise